International Journal of Cardiology
Volume 139, Issue 1 , Page 1 , 18 February 2010

Chinese patients require lower dosage of warfarin

Received 29 June 2009 ,Accepted 29 June 2009.

References 

  1. Miura T, Nishinaka T, Terada T, Yonezawa K. Relationship between aging and dosage of warfarin: the current status of warfarin anticoagulant therapy for Japanese outpatients in a department of cardiovascular medicine. J Cardiol. 2009;53:355–360
  2. Cheng TO. Maintenance doses of warfarin in Chinese patients. Q J Med. 1996;89:557
  3. Cheng TO. Underuse of antithrombotic and antiplatelet treatments for acute coronary syndrome in China: a note of caution. Chin Med J. 2009;122:1120
  4. Ross AM, Gao R, Coyne KS, et al. A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. Am Heart J. 2001;142:244–247
  5. Cheng TO. Herbal interactions with cardiac drugs. Arch Intern Med. 2000;160:870–871
  6. Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol. 2007;121:9–22
  7. Cheng TO. Comment: drug–herb interaction. Ann Pharmacotherapy. 2001;35:124
  8. Cheng TO. Warfarin danshen interaction. Ann Thorac Surg. 1999;67:894
  9. Cheng TO. Interaction of herbal medicine with Coumadin. J Emerg Med. 2000;18:122
  10. Cheng TO. Ask patients which herbal drugs they smoke as well as eat. West J Med. 2000;172:82
  11. Cheng TO. Prevention of cardiovascular disease in modern China: utile or futile?. CVD Prev Control. 2009;4:1–7
  12. Cheng TO. Potential interaction between soy milk and warfarin. Am Fam Phys. 2004;70:1231
  13. Cheng TO. Wafarin interaction with herbal drugs and food. Int J Cardiol. 2007;119:107–108
  14. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(09)00753-0

doi: 10.1016/j.ijcard.2009.06.056

International Journal of Cardiology
Volume 139, Issue 1 , Page 1 , 18 February 2010

Article Tools